. 2016 May 23;6:26010. doi: 10.1038/srep26010

Table 2. Summary of the peaks shown in Fig. 12 and the reduced muropeptides in HPLC fractions obtained from E. coli D456 peptidoglycan treated with either Bd0468 or Bd3279 detected by LTQ-FT MS¹.

Peak Number	Proposed Structure(s)¹	Theoretical neutral mass (Da)	Measured neutral mass (Da)
1	Tetra	941.4077	941.4071
2	TetraTetra	1864.8049	1864.8018
3	TetraTetra[deAc]^‡	1822.7943	1822.7932
4	TetraTetra[deAc]^‡	1822.7943	1822.7902
	+ TetraTetra[2x deAc]	1780.7837	1780.7846
5	TetraTetra[deAc]^‡	1822.7943	1822.7944
6	TetraTetra[deAc]^‡	1822.7943	1822.7914

Names of muropeptides are according to Glauner²¹ Modifications: [deAc], deacetylation of GlcNAc; ^‡ position of the deacetylated GlcNAc residue is not known.

Table 2. Summary of the peaks shown in Fig. 12 and the reduced muropeptides in HPLC fractions obtained from E. coli D456 peptidoglycan treated with either Bd0468 or Bd3279 detected by LTQ-FT MS1.

Table 2. Summary of the peaks shown in Fig. 12 and the reduced muropeptides in HPLC fractions obtained from E. coli D456 peptidoglycan treated with either Bd0468 or Bd3279 detected by LTQ-FT MS¹.